Physician profile
Steven E Roser
NPI 1992716872
$101,841.89
in general payments reported to CMS, 2019-2025
17 companies · $39K in 2025
The $39K reported for 2025 was more than what 89% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,195 · 2021: $1,520 · 2022: $5,467 · 2023: $13K · 2024: $42K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $73K · Travel and Lodging: $18K · Food and Beverage: $2,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $73,151.35 |
| Travel and Lodging | $17,815.25 |
| Food and Beverage | $2,693.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $39,398.47 | 2023-2025 | Hintermann, Dynex, Redemption |
| Restor3d, INC. | $19,679.69 | 2024-2025 | |
| Surgical Fusion INC. | $10,609.60 | 2023-2024 | Suprafusion |
| Medline Industries Lp | $8,505.24 | 2024-2025 | Medline Industries, INC., Medline, Pending |
| Flower Orthopedics Coporation | $6,590.73 | 2022-2024 | Fibula Nail, 3.5mm X 180mm, Titanium, Flex-Thread, Fibula Nail, 4.5mm X 130mm, Titanium, Flex-Thread, Fibula Nail, 3.5mm X 130mm, Titanium, Flex-Thread |
| Medartis INC. | $5,599.46 | 2021-2022 | |
| International Life Sciences | $4,500.00 | 2023-2024 | Flexband |
| Exactech, INC. | $4,069.82 | 2023 | |
| Steelhead Surgical INC | $1,224.56 | 2021 | |
| Wright Medical Technology, INC. | $918.21 | 2019 | |
| Treace Medical Concepts, INC. | $231.59 | 2025 | |
| Stryker Corporation | $224.95 | 2019-2024 | Infinity, Inbone, Infinity Adaptis |
| Medical Device Business Services, INC. | $121.86 | 2019 | |
| Carbofix Orthopedics INC | $82.77 | 2023 | |
| Smith+Nephew, INC. | $72.27 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $12.67 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$408,073.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Roser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.